These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 12490606)

  • 1. Acquisition, expression, and reinstatement of ethanol-induced conditioned place preference in mice: effects of opioid receptor-like 1 receptor agonists and naloxone.
    Kuzmin A; Sandin J; Terenius L; Ogren SO
    J Pharmacol Exp Ther; 2003 Jan; 304(1):310-8. PubMed ID: 12490606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence in locomotion test for the functional heterogeneity of ORL-1 receptors.
    Kuzmin A; Sandin J; Terenius L; Ogren SO
    Br J Pharmacol; 2004 Jan; 141(1):132-40. PubMed ID: 14662736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The opioid receptor like-1 receptor agonist Ro 64-6198 (1S,3aS-8-2,3,3a,4,5,6-hexahydro-1H-phenalen-1-yl-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-one) produces a discriminative stimulus in rats distinct from that of a mu, kappa, and delta opioid receptor agonist cue.
    Recker MD; Higgins GA
    J Pharmacol Exp Ther; 2004 Nov; 311(2):652-8. PubMed ID: 15226383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous nociceptin (orphanin FQ) suppresses basal hedonic state and acute reward responses to methamphetamine and ethanol, but facilitates chronic responses.
    Sakoori K; Murphy NP
    Neuropsychopharmacology; 2008 Mar; 33(4):877-91. PubMed ID: 17522627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-peptidergic OP4 receptor agonist inhibits morphine antinociception but does not influence morphine dependence.
    Kotlinska J; Wichmann J; Rafalski P; Talarek S; Dylag T; Silberring J
    Neuroreport; 2003 Mar; 14(4):601-4. PubMed ID: 12657894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of naloxone on expression and acquisition of ethanol place conditioning in rats.
    Bormann NM; Cunningham CL
    Pharmacol Biochem Behav; 1997 Dec; 58(4):975-82. PubMed ID: 9408203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological characterization of the novel nonpeptide orphanin FQ/nociceptin receptor agonist Ro 64-6198: rapid and reversible desensitization of the ORL1 receptor in vitro and lack of tolerance in vivo.
    Dautzenberg FM; Wichmann J; Higelin J; Py-Lang G; Kratzeisen C; Malherbe P; Kilpatrick GJ; Jenck F
    J Pharmacol Exp Ther; 2001 Aug; 298(2):812-9. PubMed ID: 11454946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different roles of mu-, delta- and kappa-opioid receptors in ethanol-associated place preference in rats exposed to conditioned fear stress.
    Matsuzawa S; Suzuki T; Misawa M; Nagase H
    Eur J Pharmacol; 1999 Feb; 368(1):9-16. PubMed ID: 10096764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nociceptin/orphanin FQ receptor agonist Ro 64-6198 reduces alcohol self-administration and prevents relapse-like alcohol drinking.
    Kuzmin A; Kreek MJ; Bakalkin G; Liljequist S
    Neuropsychopharmacology; 2007 Apr; 32(4):902-10. PubMed ID: 16880770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of morphine-conditioned place preference is more vulnerable than naloxone-conditioned place aversion to disruption by nociceptin in mice.
    Sakoori K; Murphy NP
    Neurosci Lett; 2008 Oct; 443(2):108-12. PubMed ID: 18662746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ro 64-6198 [(1S,3aS)-8-(2,3,3a,4,5,6-Hexahydro-1H-phenalen-1-yl)-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-one] acts differently from nociceptin/orphanin FQ in rat periaqueductal gray slices.
    Chiou LC; Chuang KC; Wichmann J; Adam G
    J Pharmacol Exp Ther; 2004 Nov; 311(2):645-51. PubMed ID: 15254141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orphanin FQ/nociceptin but not Ro 65-6570 inhibits the expression of cocaine-induced conditioned place preference.
    Kotlińska J; Wichmann J; Legowska A; Rolka K; Silberring J
    Behav Pharmacol; 2002 May; 13(3):229-35. PubMed ID: 12122313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence.
    Witkin JM; Statnick MA; Rorick-Kehn LM; Pintar JE; Ansonoff M; Chen Y; Tucker RC; Ciccocioppo R
    Pharmacol Ther; 2014 Mar; 141(3):283-99. PubMed ID: 24189487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nociceptin and the NOP receptor in aversive learning in mice.
    Adem A; Madjid N; Kahl U; Holst S; Sadek B; Sandin J; Terenius L; Ögren SO
    Eur Neuropsychopharmacol; 2017 Dec; 27(12):1298-1307. PubMed ID: 29102248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of the new enkephalin derivative, cyclo[N(ε),N(β)-carbonyl-d-Lys(2),Dap(5)] enkephalinamide (cUENK6), on reinstatement of ethanol-induced conditioned place preference in rats.
    Gibula-Bruzda E; Marszalek-Grabska M; Gawel K; Witkowska E; Izdebski J; Kotlinska JH
    Physiol Behav; 2015 Jun; 145():50-6. PubMed ID: 25817357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of a systemically active ORL-1 agonist, Ro 64-6198, on the acquisition, expression, extinction, and reinstatement of morphine conditioned place preference.
    Shoblock JR; Wichmann J; Maidment NT
    Neuropharmacology; 2005 Sep; 49(4):439-46. PubMed ID: 15919100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of the selective ORL1 receptor agonist, Ro64-6198, on rodent neurological function.
    Higgins GA; Grottick AJ; Ballard TM; Richards JG; Messer J; Takeshima H; Pauly-Evers M; Jenck F; Adam G; Wichmann J
    Neuropharmacology; 2001 Jul; 41(1):97-107. PubMed ID: 11445190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel and Selective Nociceptin Receptor (NOP) Agonist (1-(1-((cis)-4-isopropylcyclohexyl)piperidin-4-yl)-1H-indol-2-yl)methanol (AT-312) Decreases Acquisition of Ethanol-Induced Conditioned Place Preference in Mice.
    Zaveri NT; Marquez PV; Meyer ME; Polgar WE; Hamid A; Lutfy K
    Alcohol Clin Exp Res; 2018 Feb; 42(2):461-471. PubMed ID: 29215139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central administration of nociceptin/orphanin FQ blocks the acquisition of conditioned place preference to morphine and cocaine, but not conditioned place aversion to naloxone in mice.
    Sakoori K; Murphy NP
    Psychopharmacology (Berl); 2004 Mar; 172(2):129-36. PubMed ID: 14624329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of ventral pallidal opioid receptors induces a conditioned place aversion and attenuates acquisition of cocaine place preference in the rat.
    Skoubis PD; Maidment NT
    Neuroscience; 2003; 119(1):241-9. PubMed ID: 12763085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.